Literature DB >> 31685269

Validation of the "CHIIDA" and application for PICU triage in children with complicated mild traumatic brain injury.

Katie E Neumayer1, Jill Sweney2, Stephen J Fenton3, Heather T Keenan4, Brian F Flaherty5.   

Abstract

BACKGROUND: The Children's Intracranial Injury Decision Aid (CHIIDA) was developed to predict which patients with complicated mild traumatic brain injury (cmTBI; GCS ≥13 with depressed skull fracture or intracranial injury) would achieve the composite outcome of neurosurgical intervention, intubation >24 h, or death. The study also explored the CHIIDA as a triage tool to determine need for PICU care. The purpose of this study is to externally validate the CHIIDA and assess its effects on PICU triage.
METHODS: Retrospective cohort study (January 2016 to December 2017) to validate the CHIIDA to predict the composite outcome and assess its effects as a PICU triage tool at a level 1 pediatric trauma center.
RESULTS: Of 345 patients with cmTBI, the composite outcome occurred in 16 patients (4.6%). At a cutoff score of 2, the CHIIDA predicted the composite outcome with a sensitivity of 94% (95% CI 67-99%) and specificity of 69% (95% CI 64-74%), similar to the original study. Using the same cutoff score for PICU triage resulted in 48 (71%) more patients admitted to PICU.
CONCLUSIONS: In our cohort, the CHIIDA predicted the composite outcome well. If applied as a triage tool, it would have resulted in increased unnecessary PICU admissions. LEVEL OF EVIDENCE: Level III, prognosis. Published by Elsevier Inc.

Entities:  

Keywords:  Mild traumatic brain injury; Pediatric trauma

Year:  2019        PMID: 31685269     DOI: 10.1016/j.jpedsurg.2019.09.027

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Usability and Acceptability of Clinical Decision Support Based on the KIIDS-TBI Tool for Children with Mild Traumatic Brain Injuries and Intracranial Injuries.

Authors:  Jacob K Greenberg; Ayodamola Otun; Pyi Theim Kyaw; Christopher R Carpenter; Ross C Brownson; Nathan Kuppermann; David D Limbrick; Randi E Foraker; Po-Yin Yen
Journal:  Appl Clin Inform       Date:  2022-04-27       Impact factor: 2.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.